Novo Nordisk and Mylan Pharmaceuticals, now part of Viatris, have settled their patent dispute over Novo’s blockbuster diabetes drug Ozempic.
The Danish company declined to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
What You Should Know: – Elucid, a medical technology company providing AI-powered imaging analysis software to assess cardiovascular disease, has raised $80M in Series C
High-profile gene editing startup Tome Biosciences said in a legal filing Friday that it will terminate virtually its entire staff beginning Nov. 1. The Massachusetts
Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results Over 10x year-over-year increase in operating cash flow CHICAGO–(BUSINESS WIRE)– Cresco